273 Views | 168 Downloads
Helmut M. Diepolder: hdiepold@med.uni-muenchen.de
Conceived and designed the experiments: RP ML PK HD AU GP.
Performed the experiments: ML RT PK AU KP MH SG AR HN MO AH.
Analyzed the data: ML RT NS TS CD HD TB AU KP SG NG MJ GP HN MO AH WS.
Contributed reagents/materials/analysis tools: RP PK JW NS SF TS CD TB NG MJ RZ TS TG WS.
Wrote the paper; Conceived and designed the study; Enrolled patients; Wrote the first draft of the paper: HD.
Contributed equally: ML and AU
See Publication for full list of authors.
The authors would like to thank the patients and clinicians involved in this study.
The authors have declared that no competing interests exist.
This work was supported by funding from the Wellcome Trust, the James Martin School of the 21st Century, Oxford and the Kompetenznetz Hepatitis HepNet (Teilprojekt 10.2.1).
This work is part of the activities of the VIRGIL European Network of Excellence on Antiviral Drug Resistance supported by a grant (LSHM-CT-2004-503359) from the Priority 1 “Life Sciences, Genomics and Biotechnology for Health” programme in the 6th Framework Programme of the EU.
© 2007 Lucas et al.